{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "regularMarketChangePercent": -1.6732283, "regularMarketPrice": 9990.0, "fiftyDayAverage": 9867.4, "fiftyDayAverageChange": 122.59961, "fiftyDayAverageChangePercent": 0.012424712, "twoHundredDayAverage": 10553.695, "twoHundredDayAverageChange": -563.6953, "twoHundredDayAverageChangePercent": -0.05341213, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1509926400000, "priceHint": 2, "marketState": "PREPRE", "exchange": "KOE", "shortName": "Kolon TissueGene", "longName": "Kolon TissueGene, Inc.", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "esgPopulated": false, "regularMarketChange": -170.0, "regularMarketTime": 1683873027, "regularMarketDayHigh": 10160.0, "regularMarketDayRange": "9950.0 - 10160.0", "regularMarketDayLow": 9950.0, "regularMarketVolume": 101165, "regularMarketPreviousClose": 10160.0, "bid": 9980.0, "ask": 10030.0, "fullExchangeName": "KOSDAQ", "regularMarketOpen": 10160.0, "averageDailyVolume3Month": 146715, "averageDailyVolume10Day": 136805, "fiftyTwoWeekLowChange": 1570.0, "fiftyTwoWeekLowChangePercent": 0.18646081, "fiftyTwoWeekRange": "8420.0 - 24500.0", "fiftyTwoWeekHighChange": -14510.0, "fiftyTwoWeekHighChangePercent": -0.5922449, "fiftyTwoWeekLow": 8420.0, "fiftyTwoWeekHigh": 24500.0, "symbol": "950160.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "9713 Key West Avenue", "address2": "Suite 300", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 921 6000", "fax": "301 921 6011", "website": "https://www.tissuegene.com", "industry": "", "sector": "", "longBusinessSummary": "Kolon TissueGene, Inc. engages in developing cell therapies to target various orthopedic diseases and degenerative disorders. It develops cell therapies for osteoarthritis, including knee and hip; musculoskeletal system disorder comprising spinal disk; and vet medicine for knee. The company has collaboration with Kolon Life Science, Inc. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. Kolon TissueGene, Inc. was incorporated in 1999 and is based in Rockville, Maryland.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Moon-jong  Noh Ph.D.", "title": "Co-CEO, Co-Pres & Director", "fiscalYear": 2020, "totalPay": {"raw": 542823000, "fmt": "542.82M", "longFmt": "542,823,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sung  Han Ph.D.", "title": "Co-CEO, Co-Pres & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jung In Kim", "title": "CFO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sean  Woo", "title": "VP of Bus. Devel. & Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sun Jin Kim M.D., Ph.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1609372800, "maxAge": 86400}}], "error": null}}